Profile
Presently, Thomas Schäfer holds the position of Chief Scientific Officer & Executive VP at Chr. Hansen Holding A. He is also on the board of Bioinnovation Institute. In the past he was Head-Business Development for Novozymes A. He received a doctorate from Freie Universität Berlin.
Latest news about Thomas Schäfer
Thomas Schäfer active positions
| Companies | Position | Start |
|---|---|---|
Bioinnovation Institute
Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Director/Board Member | - |
BacThera AG
BacThera AG Pharmaceuticals: MajorHealth Technology Manufactures bio therapeutic products | Director/Board Member | - |
Former positions of Thomas Schäfer
| Companies | Position | End |
|---|---|---|
| CHRISTIAN HANSEN | Chief Tech/Sci/R&D Officer | 2022-03-30 |
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Corporate Officer/Principal | - |
Training of Thomas Schäfer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Novozymes A/S
Novozymes A/S Chemicals: SpecialtyProcess Industries Manufactures and sells specialty chemicals | Process Industries |
Freie Universität Berlin
Freie Universität Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Chr. Hansen Holding A/S
Chr. Hansen Holding A/S Food: Specialty/CandyConsumer Non-Durables Manufactures food cultures, enzymes and nutrition products | Consumer Non-Durables |
Bioinnovation Institute
Bioinnovation Institute Investment ManagersFinance BioInnovation Institute invests in companies located in Europe. The firm targets companies operating in technology sectors such as therapeutics, health tech, planetary health and quantum tech. It provides financing for early stage capital requirements with an investment size ranging from DKK 7.86 to 14 million. | Finance |
BacThera AG
BacThera AG Pharmaceuticals: MajorHealth Technology Manufactures bio therapeutic products | Health Technology |
- Stock Market
- Insiders
- Thomas Schäfer
















